IceCure Medical Ltd (ICCM) has a consensus analyst rating of Buy, based on 2 analysts covering the stock. Of those, 2 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for ICCM is $3.51, representing a +889.6% upside from the current price of $0.3547. Price targets range from a low of $2.00 to a high of $5.75.
